■Pyrimidinecarboxylic acid;■Investigational for breast carcinoma (phase 1), chronic lymphocytic leukemia (phase 1), diabetic neuropathy (phase 2), multiple myeloma (phase 1), peripheral nervous system disease (phase 1), hilar cholangiocarcinoma (phase 1), and lymphoma (phase 1);■Histone deacetylase 6 (HDAC6) inhibitor. The gene discussed is HDAC6; the disease is diabetic neuropathy.